After a long wait, two arrive, one after the other!

Thorax

Volumn 68, Issue 4, 2013, Pages 311-312

  Southern, Kevin W ^a   McCormack, Pamela ^b   McNamara, Paul S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; COLISTIN; TOBRAMYCIN;

AEROSOL; CYSTIC FIBROSIS; DRUG COST; DRUG DELIVERY SYSTEM; EDITORIAL; HEALTH CARE COST; HUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; POWDER INHALER; PRESCRIPTION; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION;

EID: 84875216270     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202891     Document Type: Editorial

References (12)

1. Southern KW. Cystic fibrosis and formes frustes of CFTR-related disease. Respiration 2007;74:241-51. (Pubitemid 46828133)
2. O'Sullivan BP, Flume P. The clinical approach to lung disease in patients with cystic fibrosis. Semin Respir Crit Care Med 2009;30:505-13.
3. Jones AP, Wallis C. Dornase alfa for cystic fibrosis. Cochrane Database Syst Rev (Online). 2010;3: CD001127.
4. Ryan G, Singh M, Dwan K. Inhaled antibiotics for long-term therapy in cystic fibrosis. Cochrane Database Syst Rev (Online). 2011;3:CD001021.
5. Geller DE, Rubin BK. Respiratory care and cystic fibrosis. Respir Care 2009;54:796-800.
6. Grasemann H, Ratjen F. Emerging therapies for cystic fibrosis lung disease. Expert Opin Emerg Drugs 2010;15:653-9.
7. Denyer J, Nikander K, Smith NJ. Adaptive Aerosol Delivery (AAD) technology. Expert Opin Drug Deliv 2004;1:165-76. (Pubitemid 40297963)
8. McCormack P, McNamara PS, Southern KW. A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis. J Cyst Fibros 2011;10:343-9.
9. McCormack P, Southern KW, McNamara PS. New nebulizer technology to monitor adherence and nebulizer performance in cystic fibrosis. J Aerosol Med Pulm Drug Deliv 2012;25:307-9.
10. McNamara PS, McCormack P, McDonald AJ, et al. Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis. J Cyst Fibros 2009;8:258-63.
11. Daniels T, Goodacre L, Sutton C, et al. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest 2011;140:425-32.
12. Ball R, Southern KW, McCormack P, et al. Adherence to nebulised therapies in adolescents with cystic fibrosis is best on week-days during school term time. J Cyst Fibros 2013; In press.